23andMe (ME) - News Mentions

Sign up to add (ME) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 2 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 100%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
November 20
Could You Get $10,000 From 23andMe's Data Breach Settlement? Here's What to Know
November 19
As 23andMe Crumbles, It Ceases All Efforts to Develop Drugs Using DNA Data
November 17
Tech layoffs update: AMD, iRobot, 23andMe, and other big firms see job losses in November 2024
November 15
Victims of 23andMe's Data Breach Could Get $10,000. Here's What You Need to Know
November 15
What the headlong fall of 23andMe signals for India’s genetic-testing market
November 14
What 23andMe business troubles could mean for millions of users' genetic data
November 14
23andMe says it faces financial hardships and has doubts it can still operate
November 13
23andMe customer? What to know about the privacy of your genetic data
November 13
What 23andMe business troubles could mean for users' genetic data
November 13
Amid 'Substantial Doubt,' 23andMe Cuts 40% of Workers
November 13
23andMe lays off 40% of its workforce, ends therapeutics division
November 13
23andMe to lay off more than 200 employees amid business struggles
November 12
23andMe Gives Up on its Drug Development Dream
November 12
23andMe to lay off 40% of its workforce as stock price plummets
November 12
What happens to customer data as 23andMe goes out of business?
November 12

Month over Month

Est. daily news mentions.

Oct 2024 1
Sep 2024 1
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is 23andMe mentioned in the news?

23andMe was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is 23andMe performing compared to its industry peers?

23andMe underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of 23andMe in the last month?

There has been no significant change in the number of news mentions for 23andMe's compared to the last month.

Why is it important to track news mentions for 23andMe?

By monitoring mentions in the news for 23andMe, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of 23andMe, ultimately improving their investment strategies.

Sign up and get more insights on 23andMe.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact